[{"address1": "302 East Pettigrew St.", "address2": "Suite A-100", "city": "Durham", "state": "NC", "zip": "27701", "country": "United States", "phone": "919 314 5512", "fax": "480 393 5553", "website": "https://precisionbiosciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-3243 for the treatment of m.3243 associated mitochondrial myopathy. In addition, the company develops PBGENE-NVS (insertion) for sickle cell and beta thalassemia diseases; PBGENE-DMD (excision) for duchenne muscular dystrophy; PBGENE-LIVER (insertion), a liver directed target; PBGENE-CNS (excision), a central nervous system directed target; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with Novartis Pharma AG to discover and develop in vivo gene editing products; TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; and iECURE, Inc. to develop ARCUS-based gene-insertion therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.", "fullTimeEmployees": 107, "companyOfficers": [{"maxAge": 1, "name": "Mr. Michael  Amoroso", "age": 46, "title": "President, CEO & Director", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 1094351, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jefferson J. Smith Ph.D.", "age": 51, "title": "Co-Founder & Chief Research Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 640195, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Alexander Kelly R.Ph.", "age": 57, "title": "CFO & Principal Accounting Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 671382, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cassie  Gorsuch Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Naresh  Tanna", "title": "Chief of Staff to CEO & Head of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dario  Scimeca J.D.", "age": 48, "title": "General Counsel & Secretary", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 576432, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Juli  Blanche", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cindy  Atwell", "title": "Chief Development & Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Neil  Leatherbury M.S.", "title": "Senior VP and Head of Chemistry, Manufacturing & Controls", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 5, "compensationRisk": 7, "shareHolderRightsRisk": 9, "overallRisk": 7, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.26, "open": 4.24, "dayLow": 4.19, "dayHigh": 4.38, "regularMarketPreviousClose": 4.26, "regularMarketOpen": 4.24, "regularMarketDayLow": 4.19, "regularMarketDayHigh": 4.38, "payoutRatio": 0.0, "beta": 1.468, "forwardPE": -0.640118, "volume": 60625, "regularMarketVolume": 60625, "averageVolume": 269739, "averageVolume10days": 977630, "averageDailyVolume10Day": 977630, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 48122788, "fiftyTwoWeekLow": 3.61, "fiftyTwoWeekHigh": 11.09, "priceToSalesTrailing12Months": 0.9409825, "fiftyDayAverage": 4.9491, "twoHundredDayAverage": 5.97735, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -904417, "profitMargins": -0.42991, "floatShares": 9117190, "sharesOutstanding": 11088200, "sharesShort": 545676, "sharesShortPriorMonth": 646361, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.049200002, "heldPercentInsiders": 0.11073, "heldPercentInstitutions": 0.42729, "shortRatio": 7.13, "shortPercentOfFloat": 0.0508, "impliedSharesOutstanding": 11088200, "bookValue": 4.677, "priceToBook": 0.9279453, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -21986000, "trailingEps": -2.87, "forwardEps": -6.78, "lastSplitFactor": "1:30", "lastSplitDate": 1707868800, "enterpriseToRevenue": -0.018, "enterpriseToEbitda": 0.022, "52WeekChange": -0.5333333, "SandP52WeekChange": 0.12677538, "quoteType": "EQUITY", "currentPrice": 4.34, "targetHighPrice": 60.0, "targetLowPrice": 13.0, "targetMeanPrice": 30.5, "targetMedianPrice": 24.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 77223000, "totalCashPerShare": 6.964, "ebitda": -41431000, "totalDebt": 29748000, "quickRatio": 6.232, "currentRatio": 6.625, "totalRevenue": 51141000, "debtToEquity": 60.296, "revenuePerShare": 6.481, "returnOnAssets": -0.17826, "returnOnEquity": -0.50808996, "grossProfits": 51141000, "freeCashflow": 6855375, "operatingCashflow": -58516000, "revenueGrowth": -0.998, "grossMargins": 1.0, "ebitdaMargins": -0.81013, "operatingMargins": -762.4827, "financialCurrency": "USD", "symbol": "DTIL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 1.87793, "regularMarketPrice": 4.34, "marketState": "CLOSED", "longName": "Precision BioSciences, Inc.", "shortName": "Precision BioSciences, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1553779800000, "postMarketChangePercent": 0.0, "postMarketPrice": 4.34, "postMarketChange": 0.0, "regularMarketChange": 0.0799999, "regularMarketDayRange": "4.19 - 4.38", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 269739, "fiftyTwoWeekLowChange": 0.73000026, "fiftyTwoWeekLowChangePercent": 0.20221615, "fiftyTwoWeekRange": "3.61 - 11.09", "fiftyTwoWeekHighChange": -6.75, "fiftyTwoWeekHighChangePercent": -0.60865647, "fiftyTwoWeekChangePercent": -53.33333, "earningsTimestamp": 1747306860, "earningsTimestampStart": 1753878600, "earningsTimestampEnd": 1754310600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.87, "epsForward": -6.78, "epsCurrentYear": -8.745, "priceEpsCurrentYear": -0.49628362, "fiftyDayAverageChange": -0.60909986, "fiftyDayAverageChangePercent": -0.123072855, "twoHundredDayAverageChange": -1.6373501, "twoHundredDayAverageChangePercent": -0.27392575, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1751574808, "regularMarketTime": 1751562000, "exchange": "NCM", "messageBoardId": "finmb_41018856", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Precision BioSciences", "trailingPegRatio": null, "__fetch_time": "2025-07-05"}]